focus -WSS

focus

author：hotspot 2025-09-30 23:20:14 - browse：4599

Cheryl Meier had watched clinical trial enrollment announcements for years — but always for her sons’ type 1 diabetes, never for herself. Her OB-GYN had put her on Effexor for her depression 20 years ago, and it worked well enough — she could sleep for the first time in her life, and she no longer cried at every little thing. But it never worked for her dark thoughts.

But then she retired, and then she had time, and then she saw an email — “I guess once your name gets on a list, it’s there,” she said — for an experimental depression drug called zuranolone.

Unlike today’s crowded market of SSRIs, prescribed once and taken for months, years, or even indefinitely, zuranolone, developed by Sage Therapeutics, promises something different.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Wegovy trial has doctors encouraged over new possibilities

knowledge

leisure time

WSS

Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

Celebrate National Dole Whip Day for 3 days this week at Disney

Couple fighting to bring baby home from Mexico are finally reunited

How dance can help health care workers heal from trauma

Researchers separate signal from noise in heart wearable data

hotspot

focus

Wikipedia

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

Guidelines to prevent youth baseball injuries need more muscle

Why failed clinical trials don’t always spell doom for a new drug

Drug repurposing or repositioning? The language matters

'Reaching a detente': STAT's Helen Branswell on covering Covid

Apple is now the first public company to be valued at $3 trillion

The best solution to the drug shortages problem

The cancer drug shortage isn’t new — and neither are the solutions

Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

Wikipedia

Wegovy trial has doctors encouraged over new possibilities

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

Methadone doses haven’t kept up in the age of fentanyl

'Reaching a detente': STAT's Helen Branswell on covering Covid

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

Wegovy’s successful heart trial raises vital question about weight loss

knowledge

hotspot

leisure time

focus